Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Eli Lilly ( LLY announced Thursday that its daily obesity pill, orforglipron, met company goals in the first of several late-stage trials — helping patients with Type 2 diabetes lower their blood sugar while causing weight loss. The results were comparable with other GLP-1 injections on the market, such as Ozempic and Mounjaro. Orforglipron could give Lilly a key advantage over other pharmaceutical giants in the GLP-1 realm. Lilly's stock was up 11% in premarket trading. Novo Nordisk ( NVO ), which makes Ozempic, was down 6%. The results are pivotal: While the GLP-1 class of medication has become a blockbuster on the market (both for diabetes treatment and weight loss), they're expensive, must be injected, and need to be kept refrigerated. A pill version would be a more convenient option that could be much more widely used. Lilly expects to file for global regulatory approval of orforglipron for weight management by the end of the year and for Type 2 diabetes in 2026. The phama
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Lilly to participate in J.P. Morgan Healthcare ConferencePR Newswire
- Eli Lilly and Company (NYSE:LLY) was given a new $1,230.00 price target on by analysts at Daiwa Capital Markets. They now have a "buy" rating on the stock.MarketBeat
- Where Will Eli Lilly Be in 10 Years? [Yahoo! Finance]Yahoo! Finance
- 2 Predictions for Eli Lilly in 2026 [Yahoo! Finance]Yahoo! Finance
- Why Eli Lilly (LLY) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/8/25 - Form 3
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- LLY's page on the SEC website